{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T07:12:13Z","timestamp":1791270733103,"version":"4.1.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"19","license":[{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,7,16]],"date-time":"2013-07-16T00:00:00Z","timestamp":1373932800000},"content-version":"vor","delay-in-days":623,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1016\/j.jacc.2011.04.049","type":"journal-article","created":{"date-parts":[[2011,10,26]],"date-time":"2011-10-26T22:05:06Z","timestamp":1319666706000},"page":"1958-1966","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":121,"title":["Eplerenone Survival Benefits in Heart Failure Patients Post-Myocardial Infarction Are Independent From its Diuretic and Potassium-Sparing Effects"],"prefix":"10.1016","volume":"58","author":[{"given":"Patrick","family":"Rossignol","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00ebl","family":"M\u00e9nard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renaud","family":"Fay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Finn","family":"Gustafsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertram","family":"Pitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faiez","family":"Zannad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2011.04.049_bib1","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.jacc.2008.11.012","article-title":"The cardiorenal syndrome: do we need a change of strategy or a change of tactics?","volume":"53","author":"Jessup","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2011.04.049_bib2","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1056\/NEJMoa010641","article-title":"Prognostic importance of elevated jugular venous pressure and a third heart sound in patients with heart failure","volume":"345","author":"Drazner","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2011.04.049_bib3","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1067\/mhj.2000.110933","article-title":"Freedom from congestion predicts good survival despite previous class iv symptoms of heart failure","volume":"140","author":"Lucas","year":"2000","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2011.04.049_bib4","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","article-title":"Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction","volume":"348","author":"Pitt","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2011.04.049_bib5","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.4065\/80.12.1623","article-title":"Aldosterone receptor antagonists in the medical management of chronic heart failure","volume":"80","author":"Tang","year":"2005","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jacc.2011.04.049_bib6","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1161\/CIRCULATIONAHA.108.809194","volume":"119","author":"Iraqi","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2011.04.049_bib7","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1172\/JCI102501","article-title":"Water diuresis produced during recumbency by the intravenous infusion of isotonic saline solution","volume":"30","author":"Strauss","year":"1951","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jacc.2011.04.049_bib8","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1016\/S0735-1097(02)01903-4","article-title":"The regulation and measurement of plasma volume in heart failure","volume":"39","author":"Kalra","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2011.04.049_bib9","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.ejheart.2008.08.005","article-title":"ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology","volume":"10","author":"Dickstein","year":"2008","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2011.04.049_bib10","doi-asserted-by":"crossref","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","article-title":"A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation","volume":"130","author":"Levey","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacc.2011.04.049_bib11","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1016\/j.amjcard.2004.01.070","article-title":"Relation of unrecognized hypervolemia in chronic heart failure to clinical status, hemodynamics, and patient outcomes","volume":"93","author":"Androne","year":"2004","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2011.04.049_bib12","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure","volume":"341","author":"Pitt","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2011.04.049_bib13","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0167-5273(01)00600-3","article-title":"Current evidence supporting the role of diuretics in heart failure: a meta analysis of randomised controlled trials","volume":"82","author":"Faris","year":"2002","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacc.2011.04.049_bib14","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1016\/j.amjcard.2005.12.072","article-title":"Relation of loop diuretic dose to mortality in advanced heart failure","volume":"97","author":"Eshaghian","year":"2006","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2011.04.049_bib15","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1067\/mhj.2002.123144","article-title":"Diuretic resistance predicts mortality in patients with advanced heart failure","volume":"144","author":"Neuberg","year":"2002","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2011.04.049_bib16","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.ejheart.2007.07.011","article-title":"Relation between dose of loop diuretics and outcomes in a heart failure population: results of the ESCAPE trial","volume":"9","author":"Hasselblad","year":"2007","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2011.04.049_bib17","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1067\/mhj.2001.113995","article-title":"Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness (ESCAPE): design and rationale","volume":"141","author":"Shah","year":"2001","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2011.04.049_bib18","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.ejheart.2008.01.007","article-title":"Fluid overload in acute heart failure\u2014re-distribution and other mechanisms beyond fluid accumulation","volume":"10","author":"Cotter","year":"2008","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2011.04.049_bib19","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S0140-6736(97)08417-1","article-title":"Randomised trial of high-dose isosorbide dinitrate plus low-dose furosemide versus high-dose furosemide plus low-dose isosorbide dinitrate in severe pulmonary oedema","volume":"351","author":"Cotter","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2011.04.049_bib20","first-page":"1531","article-title":"Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trial","volume":"287","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2011.04.049_bib21","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1093\/eurheartj\/ehp144","article-title":"Weight changes after hospitalization for worsening heart failure and subsequent re-hospitalization and mortality in the everest trial","volume":"30","author":"Blair","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2011.04.049_bib22","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1001\/jama.297.12.1319","article-title":"Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST outcome trial","volume":"297","author":"Konstam","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2011.04.049_bib23","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1093\/eurheartj\/ehm091","article-title":"A propensity-matched study of the association of low serum potassium levels and mortality in chronic heart failure","volume":"28","author":"Ahmed","year":"2007","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2011.04.049_bib24","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jacc.2008.11.013","article-title":"2009 focused update incorporated into the ACC\/AHA 2005 guidelines for the diagnosis and management of heart failure in adults: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"53","author":"Hunt","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2011.04.049_bib25","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1161\/CIRCULATIONAHA.108.778811","article-title":"Serum potassium and clinical outcomes in the eplerenone post-acute myocardial infarction heart failure efficacy and survival study (EPHESUS)","volume":"118","author":"Pitt","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2011.04.049_bib26","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S0735-1097(03)00765-4","article-title":"Diuretic use, progressive heart failure, and death in patients in the studies of left ventricular dysfunction (SOLVD)","volume":"42","author":"Domanski","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2011.04.049_bib27","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1161\/01.CIR.100.12.1311","article-title":"Diuretics and risk of arrhythmic death in patients with left ventricular dysfunction","volume":"100","author":"Cooper","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2011.04.049_bib28","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1161\/01.CIR.102.22.2700","article-title":"Limitation of excessive extracellular matrix turnover may contribute to survival benefit of spironolactone therapy in patients with congestive heart failure: insights from the randomized aldactone evaluation study (RALES)","volume":"102","author":"Zannad","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2011.04.049_bib29","doi-asserted-by":"crossref","first-page":"2848","DOI":"10.1161\/01.CIR.0000039328.33137.6C","article-title":"Increased carotid wall elastic modulus and fibronectin in aldosterone-salt-treated rats: effects of eplerenone","volume":"106","author":"Lacolley","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2011.04.049_bib30","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1046\/j.1537-2995.1983.23483276879.x","article-title":"Plasma volume nomograms for use in therapeutic plasma exchange","volume":"23","author":"Buffaloe","year":"1983","journal-title":"Transfusion"},{"key":"10.1016\/j.jacc.2011.04.049_bib31","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/jca.2920030313","article-title":"Nomograms for the prediction of patient's plasma volume in plasma exchange therapy from height, weight, and hematocrit","volume":"3","author":"Sprenger","year":"1987","journal-title":"J Clin Apher"},{"key":"10.1016\/j.jacc.2011.04.049_bib32","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/S0735-1097(01)01479-6","article-title":"Circulatory response to fluid overload removal by extracorporeal ultrafiltration in refractory congestive heart failure","volume":"38","author":"Marenzi","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2011.04.049_bib33","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1161\/HYPERTENSIONAHA.109.141531","article-title":"Rapid reversal of left ventricular hypertrophy and intracardiac volume overload in patients with resistant hypertension and hyperaldosteronism: a prospective clinical study","volume":"55","author":"Gaddam","year":"2010","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2011.04.049_bib34","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1093\/ndt\/gfq252","article-title":"ADQI 7: the clinical management of the cardio-renal syndromes: work group statements from the 7th ADQI consensus conference","volume":"25","author":"Davenport","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jacc.2011.04.049_bib35","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.jacc.2005.04.038","article-title":"Eplerenone reduces mortality 30 days after randomization following acute myocardial infarction in patients with left ventricular systolic dysfunction and heart failure","volume":"46","author":"Pitt","year":"2005","journal-title":"J Am Coll Cardiol"}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109711029883?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109711029883?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T12:47:27Z","timestamp":1760014047000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109711029883"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11]]},"references-count":35,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["S0735109711029883"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2011.04.049","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2011,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Eplerenone Survival Benefits in Heart Failure Patients Post-Myocardial Infarction Are Independent From its Diuretic and Potassium-Sparing Effects","name":"articletitle","label":"Article Title"},{"value":"Journal of the American College of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2011.04.049","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}